Savant Capital LLC Has $353,000 Position in Clorox Co. (CLX)
Savant Capital LLC raised its position in shares of Clorox Co. (NYSE:CLX) by 3.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,551 shares of the company’s stock after buying an additional 80 shares during the period. Savant Capital LLC’s holdings in Clorox were worth $353,000 at the end of the most recent quarter.
Other institutional investors have also made changes to their positions in the company. Checchi Capital Advisers LLC raised its stake in Clorox by 1.0% in the second quarter. Checchi Capital Advisers LLC now owns 820 shares of the company’s stock valued at $113,000 after buying an additional 8 shares in the last quarter. Invictus RG purchased a new stake in Clorox during the first quarter valued at about $110,000. Paragon Capital Management Ltd purchased a new stake in Clorox during the second quarter valued at about $232,000. Livingston Group Asset Management CO operating as Southport Capital Management raised its stake in Clorox by 18.3% in the second quarter. Livingston Group Asset Management CO operating as Southport Capital Management now owns 2,100 shares of the company’s stock valued at $291,000 after buying an additional 325 shares in the last quarter. Finally, Sand Hill Global Advisors LLC raised its stake in Clorox by 12.7% in the first quarter. Sand Hill Global Advisors LLC now owns 2,142 shares of the company’s stock valued at $270,000 after buying an additional 241 shares in the last quarter. 70.21% of the stock is currently owned by institutional investors.
Clorox Co. (NYSE:CLX) traded up 0.96% on Thursday, hitting $122.73. The stock had a trading volume of 1,081,533 shares. The firm’s 50-day moving average price is $127.11 and its 200-day moving average price is $129.97. The firm has a market cap of $15.89 billion, a P/E ratio of 24.95 and a beta of 0.29. Clorox Co. has a 1-year low of $118.47 and a 1-year high of $140.47.
Clorox (NYSE:CLX) last released its earnings results on Wednesday, August 3rd. The company reported $1.26 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.28 by $0.02. The business earned $1.60 billion during the quarter, compared to analyst estimates of $1.58 billion. Clorox had a net margin of 11.25% and a return on equity of 296.91%. The business’s quarterly revenue was up 2.8% compared to the same quarter last year. During the same period last year, the business earned $1.44 EPS. On average, equities research analysts predict that Clorox Co. will post $5.49 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, November 14th. Shareholders of record on Wednesday, October 26th will be issued a $0.80 dividend. This represents a $3.20 dividend on an annualized basis and a yield of 2.61%. The ex-dividend date of this dividend is Monday, October 24th. Clorox’s dividend payout ratio (DPR) is currently 64.91%.
Several equities research analysts recently issued reports on CLX shares. Jefferies Group reissued a “hold” rating on shares of Clorox in a research report on Wednesday, August 3rd. B. Riley reissued a “neutral” rating and set a $109.00 price target on shares of Clorox in a research report on Tuesday, August 9th. Atlantic Securities started coverage on Clorox in a research report on Tuesday, June 14th. They set a “neutral” rating and a $138.00 price target on the stock. Deutsche Bank AG reissued a “hold” rating and set a $134.00 price target (up from $130.00) on shares of Clorox in a research report on Sunday, July 24th. Finally, Zacks Investment Research lowered Clorox from a “hold” rating to a “sell” rating in a research report on Tuesday, July 5th. Two analysts have rated the stock with a sell rating, eight have issued a hold rating and one has assigned a buy rating to the company. The company has an average rating of “Hold” and an average price target of $128.90.
In other Clorox news, SVP Jon M. Balousek sold 5,136 shares of the firm’s stock in a transaction that occurred on Monday, August 29th. The stock was sold at an average price of $131.14, for a total value of $673,535.04. Following the completion of the sale, the senior vice president now owns 15,384 shares in the company, valued at approximately $2,017,457.76. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Laura Stein sold 38,882 shares of the firm’s stock in a transaction that occurred on Friday, September 2nd. The stock was sold at an average price of $131.69, for a total value of $5,120,370.58. Following the completion of the sale, the executive vice president now owns 48,501 shares of the company’s stock, valued at approximately $6,387,096.69. The disclosure for this sale can be found here. 0.74% of the stock is owned by company insiders.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co. (NYSE:CLX).
Receive News & Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related companies with MarketBeat.com's FREE daily email newsletter.